United States · FDA National Drug Code directory
RIVAROXABAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68180-709_310f0bf6-9b0f-441b-afd7-b9a0f7905395
- Product NDC
- 68180-709
- Form
- TABLET, FILM COATED
- Composition / generic term
- RIVAROXABAN
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250306
- Source listing expiry
- 20271231
Source-listed ingredients
- RIVAROXABAN — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (68180-709-06) · 68180-709-06
- 90 TABLET, FILM COATED in 1 BOTTLE (68180-709-09) · 68180-709-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →